Identification of prognostic biomarkers and development of a prediction model for prostate cancer
We identified nine target genes and propose a three-gene prognostic model for outcome prediction in PCa. Our findings suggest that targeting PLXNA4 may offer new therapeutic opportunities for the treatment of PCa, including immunotherapy.
Authors
- Jingyi Jia (ORCID: https://orcid.org/0000-0003-1285-5615)
- Bowei Yin
- Feilong Miao
- RuXian Ye
- Weiqing Ning (ORCID: https://orcid.org/0009-0006-9287-5008)
- Linjin Li
- Peter Wang
- Xianghui Kong
- Wu Chen
- Qiuli Chen
- Dake Chen
Institutions
- Wenzhou Medical University (CN)
- Beijing Emergency Medical Center (CN)
- Wenzhou City People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-01-05
- DOI
- https://doi.org/10.3389/fimmu.2025.1709264
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00